REVIEW article
Front. Allergy
Sec. Rhinology
Volume 6 - 2025 | doi: 10.3389/falgy.2025.1649031
This article is part of the Research TopicRecent Advances in Rhinology 2024View all 8 articles
Acoustic Therapy for Allergic Rhinitis and Chronic Rhinosinusitis: Modulating Microbiome, Immunity and Well-Being
Provisionally accepted- 1Auckland University of Technology, Auckland, New Zealand
- 2New Zealand College of Chiropractic, Auckland, New Zealand
- 3The University of Auckland, Auckland, New Zealand
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Allergic rhinitis (AR) and chronic rhinosinusitis (CRS) are common respiratory conditions that significantly impact patient health and contribute to substantial healthcare burdens. While conventional treatments offer symptom relief, many patients continue to experience persistent symptoms, side effects, or resistance to standard therapies. This highlights the growing need for novel, non-invasive, and sustainable therapeutic strategies to manage chronic airway inflammation. This review examines acoustic therapy, an emerging non-pharmacological treatment that uses sound wave-induced vibrations as a potential adjunctive therapy for AR and CRS. Acoustic therapy shows potential benefits, including enhanced nitric oxide production, improved mucociliary clearance, and modulation of immune responses by activating mechanosensitive pathways and disrupting pathogenic biofilms. Preliminary clinical findings across some trials have reported improvements in peak nasal inspiratory flow ranging from approximately 17% to 31%, significant reductions in nasal congestion and symptom scores, such as Total Nasal Symptom Score, Sino-Nasal Outcome Test-22 (SNOT-22), and enhancements in sleep quality and patient-reported outcomes. Given this limited but expanding body of evidence, we integrate interdisciplinary insights from respiratory medicine, immunology, and microbiome science to provide a translational framework for future research. We highlight the need for rigorously designed clinical trials to assess acoustic therapy's therapeutic efficacy, safety, and long-term impact. As this field evolves, acoustic therapy holds significant potential to address unmet needs in chronic respiratory diseases and contributes to improved patient care.
Keywords: nasal disease, Vibration, allergic rhinitis, Chronic rhinosinusitis, Nitric Oxide, nasal microbiome
Received: 18 Jun 2025; Accepted: 28 Jul 2025.
Copyright: © 2025 Oluwapelumi Alao, Lau, White, Lee, Puli'uvea and Bartley. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Kelvin E. M. Lau, Auckland University of Technology, Auckland, New Zealand
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.